Pancreatic Cancer Research

ResearcherSecond Affiliated Hospital of Zhejiang UniversityActive in the last 2 years

Kezhong Tang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-7844-606X; OpenAlex author ID A5005005700. Sources: OpenAlex.

Their work

Papers
5 (first author 1, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
10
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: 2 papers · 2024: none · 2025: 1 paper

Papers 5

  1. Role of m6A RNA methylation regulators in pancreatic cancer: interactions and potential implications. Co-author DOI 10.1186/s12935-025-03922-8↗
  2. Sequential therapy for pancreatic cancer patients with synchronous oligo-hepatic metastatic lesions. Last author DOI 10.1177/03008916221110265↗
  3. A case of pancreatic cancer treated with chemotherapy combined with immunotherapy and targeted therapy. First author DOI 10.3724/zdxbyxb-2023-0258↗
  4. Efficacy and safety of FOLFIRINOX as second-line chemotherapy for advanced pancreatic cancer after gemcitabine-based therapy: A systematic review and meta-anal… Last author DOI 10.1177/03000605221093225↗
  5. Neoadjuvant therapy for patients with borderline resectable pancreatic cancer: A systematic review and meta-analysis of response and resection percentages. Co-author DOI 10.1016/j.pan.2015.11.007↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Wenjie Lu · 2 shared papers, 2022–2023 · strength 0.49
  2. Lantian Wang · 2 shared papers, 2022–2023 · strength 0.49
  3. Yu J Cao · 1 shared paper, 2025 · strength 0.33
  4. Li Liao · 1 shared paper, 2025 · strength 0.33
  5. Qiaoping Xu · 1 shared paper, 2025 · strength 0.33
  6. Xin Dong · 1 shared paper, 2023 · strength 0.31
  7. Bo Zhang · 1 shared paper, 2023 · strength 0.31
  8. Xiawei Li · 1 shared paper, 2022 · strength 0.22
  9. Yulian Wu · 1 shared paper, 2016 · strength 0.08
  10. Wenjie Qin · 1 shared paper, 2016 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.